Correlation Between Telix Pharmaceuticals and Eupraxia Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Telix Pharmaceuticals and Eupraxia Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Telix Pharmaceuticals and Eupraxia Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Telix Pharmaceuticals Limited and Eupraxia Pharmaceuticals Common, you can compare the effects of market volatilities on Telix Pharmaceuticals and Eupraxia Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Telix Pharmaceuticals with a short position of Eupraxia Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Telix Pharmaceuticals and Eupraxia Pharmaceuticals.

Diversification Opportunities for Telix Pharmaceuticals and Eupraxia Pharmaceuticals

-0.16

Correlation Coefficient

Telix Pharmaceuticals  Eupraxia Pharmaceuticals

Good diversification

The 3 months correlation between Telix and Eupraxia is -0.16. Overlapping area represents the amount of risk that can be diversified away by holding Telix Pharmaceuticals Limited and Eupraxia Pharmaceuticals Commo in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eupraxia Pharmaceuticals and Telix Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Telix Pharmaceuticals Limited are associated (or correlated) with Eupraxia Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eupraxia Pharmaceuticals has no effect on the direction of Telix Pharmaceuticals i.e., Telix Pharmaceuticals and Eupraxia Pharmaceuticals go up and down completely randomly.

Pair Corralation between Telix Pharmaceuticals and Eupraxia Pharmaceuticals

Considering the 90-day investment horizon Telix Pharmaceuticals is expected to generate 1.21 times less return on investment than Eupraxia Pharmaceuticals. But when comparing it to its historical volatility, Telix Pharmaceuticals Limited is 2.3 times less risky than Eupraxia Pharmaceuticals. It trades about 0.08 of its potential returns per unit of risk. Eupraxia Pharmaceuticals Common is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  281.00  in Eupraxia Pharmaceuticals Common on September 22, 2024 and sell it today you would earn a total of  18.00  from holding Eupraxia Pharmaceuticals Common or generate 6.41% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	40.63%
Values	Daily Returns

Telix Pharmaceuticals Limited  vs.  Eupraxia Pharmaceuticals Commo

Telix Pharmaceuticals

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Telix Pharmaceuticals Limited are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating essential indicators, Telix Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Eupraxia Pharmaceuticals

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Eupraxia Pharmaceuticals Common are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Eupraxia Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Telix Pharmaceuticals and Eupraxia Pharmaceuticals

The main advantage of trading using opposite Telix Pharmaceuticals and Eupraxia Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Telix Pharmaceuticals position performs unexpectedly, Eupraxia Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eupraxia Pharmaceuticals will offset losses from the drop in Eupraxia Pharmaceuticals' long position.

The idea behind Telix Pharmaceuticals Limited and Eupraxia Pharmaceuticals Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.